Our team conducted a literature review on the role of T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) and Lymphocyte Activation Gene 3 (LAG-3) in the tumor microenvironment and immunotherapy of ovarian cancer [11]. This evidence concerns the gene HAVCR2 and ovarian cancer.